Болезнь Уиппла и Helicobacter pylori: современное состояние проблемы
https://doi.org/10.31146/1682-8658-ecg-220-12-47-53
Аннотация
Tropheryma whipplei и Helicobacter pylori имеют общие пути передачи и эпидемиологические факторы риска. Представлен обзор актуальной литературы, отражающей взаимосвязь между болезнью Уиппла и Helicobacter pylori.
Ключевые слова
Об авторах
И. Н. Куприянова
Федеральное государственное бюджетное образовательное учреждение высшего образования «Уральский государственный медицинский университет» Министерства здравоохранения Российской Федерации
Россия
Россия
Е. А. Постникова
Федеральное государственное бюджетное образовательное учреждение высшего образования «Уральский государственный медицинский университет» Министерства здравоохранения Российской Федерации
Россия
Россия
Список литературы
1. The state of oncological care to the population of Russia in 2021 / Edited by A. D. Kaprin, V. V. Starinsky, A. O. Shakhzadova. Moscow. P. A. Herzen Moscow State Medical Research Institute - branch of the Federal State Budgetary Institution “NMIC of Radiology” of the Ministry of Health of Russia. 2022. fig. 239 (In Russ.)@@ Состояние онкологической помощи населению России в 2021 году / Под ред. А. Д. Каприна, В. В. Старинского, А. О. Шахзадовой. - М.: МНИОИ им. П. А. Герцена - филиал ФГБУ «НМИЦ радиологии» Минздрава России. 2022. илл. 239 с.
2. Zamani M., Ebrahimtabar F., Zamani V. et al. Systematic review with meta-analysis: the worldwide prevalence of Helicobacter pylori infection. Aliment Pharmacol Ther. 2018;47(7):868-876. doi: 10.1111/apt.14561.
3. Hooi J. K.Y., Lai W. Y., Suen M. M.Y. et al. Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. Gastroenterology. 2017;153(2): 420-429. doi: 10.1053/j.gastro.2017.04.022.
4. Borodin D. S., Embutnieks Yu.V., Vologzhanina L. G. et al. European Register of Helicobacter pylori (Hp-EuReg): how clinical practice in Russia has changed from 2013 to 2018. Therapeutic Archive. 2019;91(2):16-24. (In Russ.) doi: 10.26442/00403660.2019.02.000156.@@ Бородин Д. С., Эмбутниекс Ю. В., Вологжанина Л. Г. и др. Европейский регистр Helicobacter pylori (Hp-EuReg): как изменилась клиническая практика в России с 2013 по 2018 г. Терапевтический архив. 2019; 91 (2): 16-24. doi: 10.26442/00403660.2019.02.000156.
5. Biagi F., Balduzzi D., Delvino P., et al. Prevalence of Whipple’s disease in north-western Italy. Eur J Clin Microbiol Infect Dis. 2015;34(7):1347-8. doi: 10.1007/s10096-015-2357-2.
6. Relman D. A., Schmidt T. M., MacDermott R.P., Falkow S. Identification of the uncultured bacillus of Whipple’s disease. N Engl J Med. 1992;30;327(5):293-301. doi: 10.1056/NEJM199207303270501.
7. Marth T., Moos V., Müller C. et al. Tropheryma whipplei infection and Whipple’s disease. Lancet Infect Dis. 2016;16(3): e13-22. doi: 10.1016/S1473-3099(15)00537-X.
8. Hujoel I. A., Johnson D. H., Lebwohl B. et al. Tropheryma whipplei Infection (Whipple Disease) in the USA. Dig Dis Sci. 2019;64(1):213-223. doi: 10.1007/s10620-018-5033-4.
9. Kupriyanova I. N., Berdnikov R B., Bozrov R. M. Whipple’s disease: literature review and clinical observation. RMJ. Medical review.2018;26(II):85-92. (In Russ.)@@ Куприянова И. Н., Бердников Р. Б., Бозров Р. М. Болезнь Уиппла: обзор литературы и клиническое наблюдение. РМЖ. Медицинское обозрение. 2018;26(II):85-92.
10. Elchert J. A., Mansoor E., Abou-Saleh M., Cooper G. S. Epidemiology of Whipple’s Disease in the USA Between 2012 and 2017: A Population-Based National Study. Dig Dis Sci. 2019;64(5):1305-1311. doi: 10.1007/s10620-018-5393-9.
11. Kono M., Yamamoto K., Nagamatsu M., Kutsuna S. Use of polymerase chain reaction in the diagnosis of Whipple’s disease. J Infect Chemother. 2015;21(12):885-8. doi: 10.1016/j.jiac.2015.08.010.
12. Yogi T., Hokama A., Kinjo F. et al. Whipple’s disease: the first Japanese case diagnosed by electron microscopy and polymerase chain reaction.Intern Med. 2004;43(7):566-70. doi: 10.2169/internalmedicine.43.566.
13. Dolmans R. A., Boel C. H., Lacle M. M., Kusters J. G. Clinical Manifestations, Treatment, and Diagnosis of. Clinical microbiology reviews. 2017;30 (2): 529-555. doi: 10.1128/CMR.00033-16.
14. Marth T. Systematic review: Whipple’s disease (Tropheryma whipplei infection) and its unmasking by tumour necrosis factor inhibitors. Alimentary pharmacology & therapeutics. 2015; 41 (8): 709-724. doi: 10.1111/apt.13140.
15. Kucharz E. J., Kramza J., Grosicka A., Pieczyrak R. Clinical manifestations of Whipple’s disease mimicking rheumatic disorders. Reumatologia. 2021;59(2):104-110. doi: 10.5114/reum.2021.105418.
16. Bai J. C., Mazure R. M., Vazquez H. et al. Whipple’s disease. Clin Gastroenterol Hepatol. 2004; 2:849-860. doi: 10.1016/s1542-3565(04)00387-8.
17. Lagier J. C., Raoult D. Whipple’s disease and Tropheryma whipplei infections: when to suspect them and how to diagnose and treat them. Curr Opin Infect Dis. 2018;31(6):463-470. doi: 10.1097/QCO.0000000000000489.
18. Lagier J. C., Fenollar F., Lepidi H., Raoult D. Failure and relapse after treatment with trimethoprim/sulfamethoxazole in classic Whipple’s disease. J Antimicrob Chemother. 2010;65(9):2005-12. doi: 10.1093/jac/dkq263.
19. Lagier J. C., Fenollar F., Lepidi H., et al. Treatment of classic Whipple’s disease: from in vitro results to clinical outcome. J Antimicrob Chemother. 2014;69(1):219-27. doi: 10.1093/jac/dkt310.
20. Scalvini D., Cambieri P., Schiepatti A. et al. Patients with Whipple’s disease have a high prevalence of Helicobacter pylori infection. Eur J Intern Med. 2023; 111:77-81. doi: 10.1016/j.ejim.2023.02.017.
21. Flannagan R. S., Cosio G., Grinstein S. Antimicrobial mechanisms of phagocytes and bacterial evasion strategies. Nat Rev Microbiol. 2009;7: 355-366. doi: 10.1038/nrmicro2128.
22. Brumell J. H., Scidmore M. A. Manipulation of rab GTPase function by intracellular bacterial pathogens. Microbiol Mol Biol Rev. 2007;71: 636-652. doi: 10.1128/MMBR.00023-07.
23. Johansson M., Lehto M., Tanhuanpaa K. et al. The oxysterol-binding protein homologue ORP1L interacts with Rab7 and alters functional properties of late endocytic compartments. Molecular biology of the cell. 2005;16:5480-5492. doi: 10.1091/mbc.E05-03-0189.
24. Papini E., Satin B., Bucci C. et al. The small GTP binding protein rab7 is essential for cellular vacuolation induced by Helicobacter pylori cytotoxin. The EMBO journal. 2007;16:15-24. doi: 10.1093/emboj/16.1.15.
25. Mottola G., Boucherit N., Trouplin V. et al. Tropheryma whipplei, the Agent of Whipple’s Disease, Affects the Early to Late Phagosome Transition and Survives in a Rab5- and Rab7-Positive Compartment. PLoS ONE. 2004; 9(2): e89367. doi: 10.1371/journal.pone.0089367
26. Marth T., Kleen N., Stallmach A. et al. Dysregulated peripheral and mucosal Th1/Th2 response in Whipple’s disease. Gastroenterology. 2002;123:1468-77.
27. Moos V., Kunkel D., Marth T., et al. Reduced peripheral and mucosal Tropheryma whipplei-specific Th1 response in patients with Whipple’s disease. J Immunol. 2006;177:2015-22. doi: 10.4049/jimmunol.177.3.2015.
28. Desnues B., Raoult D., Mege J. L.Interleukin-16 is critical for Tropheryma whipplei replication in Whipple’s disease. J. Immunol. 205;175:4575-4582. doi: 10.4049/jimmunol.175.7.4575.
29. Le Goff M., Cornec D., Guellec D. et al. Peripheral-blood b-cell subset disturbances in inflammatory joint diseases induced by Tropheryma whipplei. PloSone. 2019;14(2):1-12. doi: 10.1371/journal.pone.0211536.
30. Tison A., Preuss P., Leleu C. et al. Rheumatological features of Whipple disease. Scientific reports. 2021;1(1):16197. doi: 10.1038/s41598-021-91671-9.
31. Desnues B., Ihrig M., Raoult D., Mege J. L. Whipple’s disease: a macrophage disease. Clin Vaccine Immunol. 2006;13(2):170-8. doi: 10.1128/CVI.13.2.170-178.2006.
32. Gobert A. P., Cheng Y., Wang J. Y. et al. Helicobacter pylori induces macrophage apoptosis by activation of arginase II. J Immunol. 2002; 1;168(9):4692-700. doi: 10.4049/jimmunol.168.9.4692.
33. Ben Azzouz E., Boumaza A., Mezouar S. et al. Tropheryma whipplei increases expression of human leukocyte antigen-G on monocytes to reduce tumor necrosis factor and promote bacterial replication. Gastroenterology. 2018; 155(5):1553-63. doi: 10.1053/j.gastro.2018.07.034.
34. Moro L., Pomari E., Leonardi M. et al. Tropheryma whipplei, Helicobacter pylori, and Intestinal Protozoal Co-Infections in Italian and Immigrant Populations: A Cross-Sectional Study. Microorganisms. 2022;10(4):769. doi: 10.3390/microorganisms10040769.
35. Keita A. K., Bassene H., Tall A., Sokhna C. et al. Tropheryma whipplei: A common bacterium in rural Senegal. PLoS Negl. Trop. Dis. 2011;5.: e1403. doi: 10.1371/journal.pntd.0001403.
36. Ramharter M., Harrison N., Bühler T. et al. Prevalence and risk factor assessment of Tropheryma whipplei in a rural community in Gabon: A community-based cross-sectional study. Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis. 2014;20:1189-1194. doi: 10.1111/1469-0691.12724.
37. Choi R. Pazevic A., Pak K. et al. A Case of Whipple’s Disease With Concomitant Esophageal Candidiasis. Mil Med. 2023;26:246. doi: 10.1093/milmed/usad246.
38. Batista M., Santos M. L., Silva C. et al. Whipple’s Disease: A Case Report. Cureus. 2023; 5;15(6): e39963. doi: 10.7759/cureus.39963.
39. Brown L. M. Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev. 2000; 22:283-97. doi: 10.1093/oxfordjournals.epirev.a018040.
40. Miyamoto R., Okuda M., Lin Y. et al. Rapidly decreasing prevalence of Helicobacter pylori among Japanese children and adolescents. J Infect Chemother. 2019; 25: 526-30. doi: 10.1016/j.jiac.2019.02.016.
41. Nguyen T. H., Mallepally N., Hammad T. et al. Prevalence of Helicobacter pylori positive non-cardia gastric adenocarcinoma is low and decreasing in a US population. Dig Dis Sci. 2020;65:2403-11. doi: 10.1007/s10620-019-05955-2.
42. Dore M. P., Marras G., Rocchi C. et al. Changing prevalence of Helicobacter pylori infection and peptic ulcer among dyspeptic Sardinian patients.Intern Emerg Med. 2015;10:787-94. doi: 10.1007/s11739-015-1218-4.
43. Stevenson T. H., Lucia L. M., Acuff G. R. Development of a selective medium for isolation of Helicobacter pylori from cattle and beef samples. Appl Environ Microbiol. 2000;66:723-7. doi: 10.1128/AEM.66.2.723-727.2000.
Рецензия
Для цитирования:
Куприянова И.Н., Постникова Е.А. Болезнь Уиппла и Helicobacter pylori: современное состояние проблемы. Экспериментальная и клиническая гастроэнтерология. 2023;(12):47-53. https://doi.org/10.31146/1682-8658-ecg-220-12-47-53
For citation:
Kupriyanova I.N., Postnikova E.A. Whipple’s disease and Helicobacter pylori: current state of the problem. Experimental and Clinical Gastroenterology. 2023;(12):47-53. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-220-12-47-53
Просмотров:
127
Послать статью по эл. почте 